SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dumb SEND IT

Dumb SEND IT ($DSIT) is gaining momentum as a community-driven low-cap memecoin on Solana, with investors actively discussing its rapid growth and the developer's commitment to community engagement through frequent airdrops and transparency. Supporters are rallying behind the project's 'dumb send' philosophy, frequently comparing its early-stage potential to other successful runners while focusing on social media trending and viral expansion.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic is experiencing heightened community engagement driven by anticipation surrounding ongoing monthly burn initiatives and the development of new ecosystem projects. Supporters are closely watching the chart for signs of a turnaround, frequently discussing the potential for a long-term recovery and increased utility within the blockchain.

Optical Cable Corp. engages in the business of manufacturing fiber optic and copper data communication cabling and connectivity solutions primarily for the enterprise market and various harsh environment, specialty markets, and the wireless carrier market offering integrated suites of high-quality products which operate as a system solution or seamlessly integrate with other components. Its products include fiber optic and copper cabling, hybrid cabling, fiber optic and copper connectors, specialty fiber optic, copper and hybrid connectors, fiber optic and copper patch cords, pre-terminated fiber optic and copper cable assemblies, racks, cabinets, datacom enclosures, patch panels, face plates, multimedia boxes, fiber optic reels, and other cable and connectivity management accessories. The company was founded on June 10, 1983 and is headquartered in Roanoke, VA.

Optical Cable Corp.

Optical Cable Corp is trending as investors monitor its role in the data center and fiber infrastructure boom, with the community closely tracking potential execution of its strategic partnership with Lightera. While sentiment remains divided between those betting on long-term value from increased fiber demand and those wary of the stock's low-float volatility and historical revenue headwinds, the ticker continues to attract attention during retail momentum cycles.

"What's Updog?" is a Community Led token.

UpDog

UpDog is generating significant community buzz through its long-standing presence on the Solana network, with holders actively promoting its organic growth and whale accumulation trends. The community remains highly engaged by leveraging the project's playful 'dad joke' branding to maintain visibility and momentum across various social platforms.

Venice boasts an innovative approach to generative AI with its unique privacy architecture, access to competitive features including multiple leading open-source LLM models such as DeepSeek R1, PDFs analysis, and image and code generation. An unrestricted AI Characters feature is available with its Pro version, Venice Pro.   VVV is designed to minimize friction and reduce costs for AI agents and developers to access private, reliable, on-demand and perpetual AI inference via Venice.ai's API.

Venice Token

Venice Token (VVV) is experiencing significant community buzz due to its aggressive token burn initiatives, a reduction in supply emissions, and its positioning as a privacy-focused decentralized AI platform. Investors are actively discussing the token's low circulating supply as a catalyst for potential volatility and are closely monitoring staking incentives as the project expands its AI inference capabilities.

NXP Semiconductors NV is a holding company which engages in the provision of semiconductor solutions. It operates through the following geographical segments: China, Netherlands, United States, Singapore, Germany, Japan, South Korea, Malaysia, and Other Countries. The company was founded on August 2, 2006, and is headquartered in Eindhoven, the Netherlands.

NXP Semiconductors NV

NXP Semiconductors is trending as investors weigh its role as a "picks-and-shovels" play in the automotive and industrial AI buildout against recent analyst downgrades citing inventory and demand concerns. The community is actively debating whether its recent price action signals a long-term value opportunity or a trap amid broader volatility in the semiconductor sector.

The Aircoin memecoin was born from a viral Twitter post from March, 2014 which proclaimed the following:   Evolution: 1. Aircoin 2. Fartcoin 3. Artcoin  Aircoin was launched in August, 2025 and CTO'd twice, with the second CTO team bringing vast experience and expertise to the project. The team includes industry veterans and visual arts professionals.  Aircoin is destined for greatness as a premier memecoin on the BONK.fun platform.

aircoin

The $AIRCOIN community is rallying behind the project's long-term vision, emphasizing its unique 'Airlock' mechanism which has over 38% of the supply locked on-chain to demonstrate deep investor conviction. Supporters frequently highlight the project's historical lore, battle-tested leadership, and growing treasury as key differentiators that position it as a durable, fundamentally-driven alternative to short-lived meme trends.

DaVita, Inc. engages in the provision of medical care services. It operates through the US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives segments. The US Dialysis and Related Lab Services segment offer kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consists primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

DaVita Inc

DaVita is currently trending as community members and investors debate the potential impact of new kidney-related drug trials on the long-term demand for dialysis services. While some fear that emerging treatments could reduce patient volumes, many market participants are pointing to the stock's oversold conditions and strong operational baseline as reasons to view the recent market volatility as a potential buying opportunity.

Algorand is a scalable, secure, and decentralized digital currency and smart contract platform. Its protocol uses a variation of Proof-of-Stake (PoS) called Pure PoS (PPoS) to secure the network and reach consensus on block production. Developers can build decentralized applications (dApps) using familiar programming languages, including Python, which Algorand supports natively. Its infrastructure enables various use cases, including payment systems, digital identity solutions, supply-chain tracking, and financial services. The protocol's architecture allows for tokenization of assets and the development of smart contracts, while its technical specifications support both retail users seeking basic transaction capabilities and enterprises requiring more, complex, blockchain solutions.

Algorand

Algorand is seeing increased social media chatter and buying activity as community members speculate on institutional accumulation and the potential for a technical price rebound. Despite ongoing debate about the project's long-term utility and historical price performance, supporters are actively discussing its quantum-resistant technology and potential for future institutional adoption.

Nomad Foods Ltd. operates as a holding company, which manufactures and sells frozen foods for human consumption. The firm offers its products under the brands LUTOSA, la Cocinera, Birds Eye, Iglo, and Findus. The company was founded by Noam Gottesman and Sir Martin E. Franklin on April 1, 2014 and is headquartered in Woking, the United Kingdom.

Nomad Foods Limited

Nomad Foods is trending as investors weigh its attractive dividend yield, aggressive share buyback programs, and low valuation against sector-wide headwinds and concerns about debt levels. The community is actively debating whether these factors signal a deep-value opportunity or a long-term value trap in the frozen food space.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>The change does not legalize marijuana but reduces regulatory hurdles and offers tax relief for licensed operators.</li><li>Trump has earlier framed the move as a step toward supporting medical research, while clarifying that it does not legalize recreational use.</li><li>The DOJ is updating procedures to speed up the rulemaking process needed to move marijuana from Schedule I to Schedule III.</li></ul>Shares of Tilray (TLRY), Canopy Growth (CGC), Aurora Cannabis (ACB), and IGC Pharma Inc (IGC) remained in focus after the U.S. Department of Justice formally moved to reclassify state-licensed medical marijuana as a less dangerous drug, four months after President Donald Trump signed an executive order to shift it from Schedule I to Schedule III.After rallying in the previous session and gaining in pre-market trading on Thursday, the stocks fell in morning trade. At the time of writing, TLRY, CGC, ACB and IGC fell between 2-5%.&nbsp;Meanwhile, AdvisorShares Pure US Cannabis ETF (MSOS) fell 5.5%.<h2 class="st-heading-2">DOJ To Update Rulemaking Processes For Reclassification</h2>While the change does not legalize marijuana, it reduces regulatory hurdles, offers tax relief for licensed operators, and makes research easier. Schedule III drugs are considered to have a moderate to low risk of dependence. Trump has earlier framed the move as a step toward supporting medical research, while clarifying that it does not legalize recreational use.“This rescheduling action allows for research on the safety and efficacy of this substance, ultimately providing patients with better care and doctors with more reliable information,”&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.justice.gov/opa/pr/justice-department-places-fda-approved-marijuana-products-and-products-containing-marijuana">said</a> Todd Blanche, acting Attorney General, in a statement.Separately, the Justice Department said it is updating procedures to speed up the rulemaking process needed to move marijuana from Schedule I to Schedule III under the Controlled Substances Act. The move is expected to expand access to medical treatments and support research, while also strengthening the legal framework for medical marijuana programs across dozens of U.S. states.<h2 class="st-heading-2">How Did Retail Traders React?</h2>Retail sentiment on Stocktwits for TLRY, CGC, ACB, and IGC turned ‘extremely bullish,’ amid ‘extremely high’ message volumes.One user said, “The weed industry is reborn.”<stembedurl>https://stocktwits.com/Lando_Calrissian/message/651131346</stembedurl>Another user said Tilray will be the “king in the U.S. cannabis market.”<stembedurl>https://stocktwits.com/Rumsen/message/651070434</stembedurl>Meanwhile, shares of nano-cap Akanda Corp. (AKAN)&nbsp;climbed 6% higher,&nbsp;extending a stunning 215% surge from the previous session, with investors and traders debating whether the explosive rally is driven by cannabis reclassification optimism or the stock’s low float.Message volumes on the Stocktwits platform for the stock surged by around 48,000% over a 24-hour period.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Legalized Marijuana In Canada (Photo by Lane Turner/The Boston Globe via Getty Images)

TLRY, CGC, ACB, MSOS Pare Early Gains After Marijuana Reclassification: Retail Says ‘Weed Industry Is Reborn’

The U.S. Department of Justice formally moved to reclassify state-licensed medical marijuana as a less dangerous drug, four months after President Donald Trump signed an executive order.

Equity

<ul class="summary-bullets"><li>In December, Trump signed an executive order directing the reclassification of marijuana from a Schedule I to a Schedule III drug in the same category as Tylenol with codeine.</li><li>During a separate Oval Office signing ceremony on psychedelics research earlier this month, Trump directly addressed delays in his own rescheduling directive, saying his administration was “slow-walking.”</li><li>A Schedule I drug classification is reserved for substances deemed to have high abuse potential and no accepted medical use such as heroin and LSD.</li></ul> The Trump administration is reportedly slated to move to reclassify marijuana as soon as Wednesday.Axios <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.axios.com/2026/04/22/trump-marijuana-rule-change">reported</a> of the upcoming move, citing an administration official. &nbsp;Shares of Tilray (TLRY) traded 13% higher at the time of writing. Other publicly traded companies in the space including Aurora Cannabis (ACB), Canopy Growth (CGC), and&nbsp; IGC Pharma Inc (IGC) jumped 10%, 20% and 6%, respectively. AdvisorShares Pure US Cannabis ETF (<a href="https://stocktwits.com/symbol/MSOS">MSOS</a>), meanwhile, rallied 23% higher.In December, Trump signed an executive order directing the reclassification of marijuana from a Schedule I to a Schedule III drug in the same category as Tylenol with codeine. The order directed Attorney General to expedite the federal reclassification process through the Drug Enforcement Administration. Trump framed the move as focused on recognizing legitimate medical uses and accelerating research, while explicitly stating it does not legalize recreational marijuana.During a separate Oval Office signing ceremony on psychedelics research earlier this month, Trump directly addressed delays in his own rescheduling directive, saying his administration was “slow-walking.”A Schedule I drug classification is reserved for substances deemed to have high abuse potential and no accepted medical use such as heroin and LSD.The Trump administration is expected to classify marijuana as a Schedule III substance, indicating that it has a lesser potential for abuse and is allowed for use in specific medical treatments, but can also create risks of physical or psychological dependence.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around TLRY and CGC are trending in the ‘extremely bullish’ territory, coupled with ‘high’ message volume.While <a href="https://stocktwits.com/symbol/TLRY">TLRY stock</a> has gained 70% over the past 12 months, <a href="https://stocktwits.com/symbol/CGC">CGC</a> has gained 16%.Read More: <a href="https://stocktwits.com/news-articles/markets/equity/rivian-stock-defies-tornado-setback-with-r2-production-kickstart/cZBBvT3ReGy">RIVN Stock Defies Tornado Setback With R2 Production Kickstart</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Cannabis plants grow in the greenhouse at Vireo Health's medical marijuana cultivation facility, August 19, 2016 in Johnstown, New York. (Photo by Drew Angerer/Getty Images)

TLRY, CGC, IGC Stocks Light Up On Trump Pot Reclassification Hopes This Week  

Axios reported on Wednesday, citing an administration official, that the Trump administration is slated to reclassify marijuana as soon as Wednesday. 

electroCore, Inc. (ECOR) Reports Q4 Loss, Lags Revenue Estimates

electroCore (ECOR) delivered earnings and revenue surprises of +1.45% and -0.18%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

4D Molecular Therapeutics, Inc. (FDMT) Q4 Earnings and Revenues Beat Estimates

4D Molecular Therapeutics (FDMT) delivered earnings and revenue surprises of +180.75% and +147.86%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Merck KGaA (MKKGY) Lags Q4 Earnings Estimates

Merck KGaA (MKKGY) delivered earnings and revenue surprises of -40.43% and +0.69%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

IGC Pharma, Inc. (IGC) Reports Q2 Loss, Misses Revenue Estimates

IGC Pharma, Inc. (IGC) delivered earnings and revenue surprises of 0.00% and -56.59%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Profound Medical (PROF) Reports Q3 Loss, Tops Revenue Estimates

Profound Medical (PROF) delivered earnings and revenue surprises of +31.58% and +0.74%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Lyra Therapeutics, Inc. (LYRA) Reports Q3 Loss, Lags Revenue Estimates

Lyra Therapeutics (LYRA) delivered earnings and revenue surprises of +43.48% and -77.27%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Theravance Biopharma (TBPH) Q3 Earnings and Revenues Beat Estimates

Theravance Bio (TBPH) delivered earnings and revenue surprises of +233.33% and +2.08%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Esperion Therapeutics (ESPR) Reports Q3 Loss, Tops Revenue Estimates

Esperion Therapeutics (ESPR) delivered earnings and revenue surprises of -77.78% and +4.75%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

IGC Pharma, Inc. is a clinical-stage pharmaceutical company that is focused on Alzheimer's disease, developing innovative solutions to address this devastating illness. It has two investigational drug assets targeting Alzheimer's disease: IGC-AD1, which is in a Phase 2 clinical trial as a treatment for agitation in dementia due to Alzheimer's and TGR-63 that is in pre-clinical development. In addition to its drug development pipeline, IGC Pharma seeks to leverage artificial intelligence (AI) for Alzheimer's research. The company was founded by Ram Mukunda on April 29, 2005 and is headquartered in Potomac, MD.

Current Price	$0.3372
Prev Close	$0.3397
Open	$0.34
Dividend Yield	0.00%
50-Day Moving Average	$0.2846
Beta	0.59
Avg. Volume	306,519.05
PE Ratio	-5.46

52-Week High	$0.4985
52-Week Low	$0.242
Market Capitalization	$33.31M
EPS (Annual)	-$0.0931
Price to Book	4.32
Revenue Per Employee	$18,157.14

IGC
IGC Pharma Inc

Feed

News

Sentiment

Fundamentals

Info

Latest IGC News

IGCIGC Pharma Inc